[Main factors affecting the effect of photodynamic therapy against human esophageal cancer cells in vitro]

Nan Fang Yi Ke Da Xue Xue Bao. 2007 Dec;27(12):1817-20.
[Article in Chinese]

Abstract

Objective: To evaluate the tumor cell-killing effect of photodynamic therapy against human esophageal cancer cells in vitro and identify the main factors affecting the effect.

Methods: Human esophageal cancer Eca-109 cells were incubated for 24 h in vitro with hematoporphyrin derivative (HpD) and Photofrin at different concentrations prior to exposure to a light energy density of 15 J/cm(2) delivered from a DIOMED 630 PDT system. The cell killing effect was also evaluated for different HpD concentrations combined with 3 light energy densities (10, 30, and 50 J/cm(2)), respectively. The cell survival rate was measured using MTT assay, and fluorescence spectrometry was used to detect the intracellular photosensitizer fluorescence of the tumor cells after incubation with HpD for 4 h.

Results: The cell survival rate after incubation with the two photosensitizers at different concentrations were significantly different, and under the 3 different light energy densities, incubation of the cells with different HpD concentrations also resulted in significantly different cell survival rates (P<0.05). At the 4 low photosensitizer concentrations and with different light energy densities, the cell survival rates were similar (P>0.05), but the 4 higher photosensitizer concentrations resulted in significant difference in the cells survival (P<0.05). Correlation analysis showed that the intracellular photosensitizer concentration was positively correlated to the photosensitizer concentrations in cell incubation (r=0.997).

Conclusion: When the light source remains constant, the light energy density, the kinds of photosensitizers and their concentrations are the main factors affecting the Eca-109 cell-killing effect of PDT.

Publication types

  • English Abstract

MeSH terms

  • Cell Line, Tumor
  • Cell Survival
  • Dihematoporphyrin Ether / pharmacology
  • Esophageal Neoplasms / drug therapy*
  • Hematoporphyrin Derivative / pharmacology
  • Hematoporphyrin Photoradiation*
  • Humans
  • Light
  • Photosensitizing Agents / pharmacology*

Substances

  • Photosensitizing Agents
  • Hematoporphyrin Derivative
  • Dihematoporphyrin Ether